Trading Analysis Report: CRM
- Analysis date: 2026-05-29
- Processed decision: Buy
- Price Target: $250
I. Analyst Team Reports
Market Analyst
Market Analyst
Investment Snapshot
| Metric | Latest value | Why it matters |
|---|---|---|
| NYSE close (May 29, 2026) | $191.10 | Entry price for the rating and target. |
| Market capitalization | $156.51B | Salesforce remains a large-cap enterprise software platform. |
| Enterprise value | $187.22B | Debt from the accelerated share repurchase makes EV important. |
| 52-week range | $163.52-$276.80 | Shares recovered from lows but remain well below the prior high. |
| 50-day / 200-day averages | $180.81 / $221.27 | Price is above the 50-day but still below the 200-day trend. |
| Forward P/E | 12.35x | Earnings multiple is low for a profitable software platform. |
| Trailing P/E | 22.12x | Current earnings multiple is reasonable after margin expansion. |
| Price/sales | 3.65x | Sales multiple is moderate relative to large-cap software peers. |
| EV/EBITDA | 14.52x | Enterprise valuation is fair given growth and margin profile. |
| Dividend yield | 0.92% | Dividend is modest; buybacks are the larger capital return lever. |
| Analyst mean / median target | $257.03 / $250.00 | Consensus implies meaningful upside from the close. |
| Analyst high / low target | $475.00 / $160.00 | Dispersion is wide, but the base-case target is above spot. |
| Q1 FY2027 revenue | $11.1B, +13% YoY | Revenue growth accelerated with AI and platform demand. |
| Q1 cRPO | $33.6B, +14% YoY | Contracted backlog supports forward revenue visibility. |
| Q1 non-GAAP operating margin | 34.8% | Margin profile remains strong while revenue grows double digits. |
| Q1 non-GAAP diluted EPS | $3.88, +50% YoY | EPS growth is the clearest operating leverage signal. |
| Q1 free cash flow | $6.6B, +4% YoY | Cash flow remains high, though growth is muted by debt-related effects. |
| Agentforce and Data 360 ARR | Nearly $3.4B, +200%+ YoY | AI platform traction supports the growth narrative. |
| FY2027 revenue guidance | $45.9B-$46.2B, +11% YoY | Guidance supports continued double-digit growth. |
| FY2027 non-GAAP margin guide | 34.3% | Management expects high profitability to persist. |
| FY2026 revenue / FCF | $41.5B / $14.4B | Establishes the annual scale and cash generation base. |
| Total debt / cash | $42.55B / $11.84B | Balance sheet risk rose after the $25B ASR-related debt issuance. |
CRM closed at $191.10 on May 29, 2026, with a market capitalization of about $156.51 billion and an enterprise value of about $187.22 billion. The stock jumped after results but remains below the 200-day average of $221.27 and far below the 52-week high of $276.80, so the chart still has recovery room if fundamentals keep improving.
The valuation setup is constructive. Salesforce trades at 12.35x forward earnings, 22.12x trailing earnings, 3.65x sales, and 14.52x EV/EBITDA. For a software company guiding to roughly 11% revenue growth and a 34% non-GAAP operating margin, that is a reasonable to attractive multiple set.
The market case supports a Buy rating with a $250 target. The target is aligned with the analyst median and below the $257.03 mean target, giving room for upside while respecting balance-sheet risk from the $25 billion accelerated share repurchase financing.
Sentiment Analyst
Sentiment Analyst
Sentiment improved sharply after Salesforce delivered record first-quarter fiscal 2027 results. Revenue rose 13% year over year to $11.1 billion, current remaining performance obligation increased 14% to $33.6 billion, and non-GAAP diluted EPS rose 50% to $3.88. The share reaction on May 29 shows investors were willing to reward the combination of growth, margin, and AI traction.
The AI narrative is now backed by measurable metrics. Agentforce and Data 360 ARR was nearly $3.4 billion, up more than 200% year over year, including $1.2 billion of Agentforce ARR. Salesforce also disclosed 3.8 billion Agentic Work Units delivered to date, up 111% quarter over quarter, and more than 28.6 trillion tokens processed to date.
The sentiment risk is that investors may debate whether AI growth can offset mature core CRM growth over multiple years. Cash-flow growth guidance of only about 4%-5% for FY2027 after the debt issuance also limits near-term enthusiasm. Sentiment is positive, but execution must remain visible.
News Analyst
News Analyst
The key news item is Salesforce's first-quarter fiscal 2027 results release dated May 27, 2026. Revenue was $11.1 billion, up 13% year over year and 12% in constant currency. Subscription and support revenue was $10.6 billion, up 14% year over year. Current remaining performance obligation was $33.6 billion, up 14%, and total remaining performance obligation was $67.9 billion, up 11%.
Profitability was strong. GAAP operating margin was 21.1%, non-GAAP operating margin was 34.8%, GAAP diluted EPS increased 52% to $2.42, and non-GAAP diluted EPS increased 50% to $3.88. Operating cash flow was $6.7 billion, up 3%, and free cash flow was $6.6 billion, up 4%.
Guidance was also important. Management guided Q2 FY2027 revenue to $11.27 billion-$11.35 billion and FY2027 revenue to $45.9 billion-$46.2 billion, or about 11% growth. FY2027 GAAP operating margin is expected to be 20.6%, non-GAAP operating margin 34.3%, and operating cash flow/free cash flow growth approximately 4%-5% after the impact of the $25 billion debt issuance for the ASR. FY2026 context shows revenue of $41.5 billion, non-GAAP operating margin of 34.1%, operating cash flow of $15.0 billion, and free cash flow of $14.4 billion.
Sources: Salesforce Q1 FY2027 results release dated May 27, 2026; Salesforce investor release; Salesforce Q4 and FY2026 results release dated February 25, 2026; market snapshot retrieved May 31, 2026 for the May 29, 2026 NYSE close.
Fundamentals Analyst
Fundamentals Analyst
Salesforce's fundamentals are stronger than the market multiple suggests. Q1 FY2027 revenue grew 13%, subscription and support revenue grew 14%, cRPO grew 14%, and non-GAAP operating margin reached 34.8%. This is a high-margin, recurring-revenue software model still growing at a double-digit rate.
The margin and cash profile remain central to the investment case. FY2026 revenue was $41.5 billion, non-GAAP operating margin was 34.1%, operating cash flow was $15.0 billion, and free cash flow was $14.4 billion. Q1 FY2027 free cash flow of $6.6 billion shows the business remains highly cash-generative even though FY2027 cash-flow growth guidance is muted by debt-related effects.
The balance sheet is the main new constraint. Salesforce returned $27.5 billion to shareholders in Q1, including $27.1 billion in repurchases, and the $25 billion accelerated share repurchase increased debt. Market data shows total debt of about $42.55 billion and cash of about $11.84 billion. The buyback supports per-share value, but it also makes execution risk more important.
II. Research Team Decision
Bull Researcher
Bull Case
The bull case is that Salesforce is priced too cheaply for its growth, margin, and AI optionality. At $191.10, the stock trades at only 12.35x forward earnings while revenue is guided to grow about 11% in FY2027 and non-GAAP operating margin is guided at 34.3%. If investors regain confidence in software growth and AI monetization, the multiple can rerate.
Agentforce and Data 360 provide a credible upside narrative. ARR was nearly $3.4 billion, up more than 200% year over year, and Agentforce ARR reached $1.2 billion. Combined with cRPO growth of 14% and the $50 billion buyback authorization, Salesforce has multiple levers for per-share value creation.
Bear Researcher
Bear Case
The bear case is that Salesforce is using financial engineering to support EPS while organic cash-flow growth slows. Q1 free cash flow grew only 4%, and FY2027 operating cash flow and free cash flow guidance is approximately 4%-5% after the impact of the $25 billion debt issuance. If debt-funded buybacks do not translate into durable growth, investors could discount the stock.
There is also execution risk around AI monetization. Agentforce metrics are impressive, but the market still needs proof that AI agents can materially accelerate total company revenue beyond the low double-digit guide. If revenue growth stays near 10%-11% and debt remains elevated, the stock may not close the gap to the analyst target range.
Research Manager
Research Manager Decision
The balanced decision is Buy. Salesforce delivered a strong Q1 FY2027 with 13% revenue growth, 14% cRPO growth, 34.8% non-GAAP operating margin, and 50% non-GAAP EPS growth. The stock still trades below its 200-day average and at a low forward earnings multiple for a profitable enterprise software platform.
Price Target: $250
The $250 target matches the analyst median target and remains slightly below the $257.03 mean target. It implies meaningful upside from $191.10 while allowing for debt and cash-flow growth concerns after the accelerated share repurchase. The rating depends on continued cRPO growth, AI platform traction, and management maintaining high margins without sacrificing durable growth.
III. Trading Team Plan
Trader
Trading Plan
Rating: Buy
Price Target: $250
Time Horizon: 6-12 months
Investment Snapshot
| Metric | Latest value | Why it matters |
|---|---|---|
| NYSE close (May 29, 2026) | $191.10 | Entry price for the rating and target. |
| Market capitalization | $156.51B | Salesforce remains a large-cap enterprise software platform. |
| Enterprise value | $187.22B | Debt from the accelerated share repurchase makes EV important. |
| 52-week range | $163.52-$276.80 | Shares recovered from lows but remain well below the prior high. |
| 50-day / 200-day averages | $180.81 / $221.27 | Price is above the 50-day but still below the 200-day trend. |
| Forward P/E | 12.35x | Earnings multiple is low for a profitable software platform. |
| Trailing P/E | 22.12x | Current earnings multiple is reasonable after margin expansion. |
| Price/sales | 3.65x | Sales multiple is moderate relative to large-cap software peers. |
| EV/EBITDA | 14.52x | Enterprise valuation is fair given growth and margin profile. |
| Dividend yield | 0.92% | Dividend is modest; buybacks are the larger capital return lever. |
| Analyst mean / median target | $257.03 / $250.00 | Consensus implies meaningful upside from the close. |
| Analyst high / low target | $475.00 / $160.00 | Dispersion is wide, but the base-case target is above spot. |
| Q1 FY2027 revenue | $11.1B, +13% YoY | Revenue growth accelerated with AI and platform demand. |
| Q1 cRPO | $33.6B, +14% YoY | Contracted backlog supports forward revenue visibility. |
| Q1 non-GAAP operating margin | 34.8% | Margin profile remains strong while revenue grows double digits. |
| Q1 non-GAAP diluted EPS | $3.88, +50% YoY | EPS growth is the clearest operating leverage signal. |
| Q1 free cash flow | $6.6B, +4% YoY | Cash flow remains high, though growth is muted by debt-related effects. |
| Agentforce and Data 360 ARR | Nearly $3.4B, +200%+ YoY | AI platform traction supports the growth narrative. |
| FY2027 revenue guidance | $45.9B-$46.2B, +11% YoY | Guidance supports continued double-digit growth. |
| FY2027 non-GAAP margin guide | 34.3% | Management expects high profitability to persist. |
| FY2026 revenue / FCF | $41.5B / $14.4B | Establishes the annual scale and cash generation base. |
| Total debt / cash | $42.55B / $11.84B | Balance sheet risk rose after the $25B ASR-related debt issuance. |
New capital can be accumulated selectively around $190-$200, with a preference for staged entries because the stock just jumped after earnings. The setup remains attractive because CRM is still below its 200-day average and far below the 52-week high, while the $250 target offers a clear upside path.
A sustained move above the 200-day average would be a constructive confirmation that investors are accepting the AI and margin story. Risk controls should tighten if the stock loses the 50-day average, if FY2027 revenue guidance is cut, or if debt-funded buybacks begin to pressure cash-flow flexibility.
IV. Risk Management Team Decision
Aggressive Analyst
Aggressive Risk View
An aggressive investor can own CRM for a valuation rerating and AI platform optionality. The stock trades at only 12.35x forward earnings, Agentforce and Data 360 ARR is growing rapidly, and the company is returning substantial capital through buybacks. If AI monetization broadens across the installed base, upside can exceed the $250 base target.
The aggressive case should still recognize timing risk. The stock moved sharply after results, and the balance sheet now carries more debt. Position sizing should account for volatility around software multiples and AI adoption expectations.
Conservative Analyst
Conservative Risk View
A conservative investor can rate CRM as Buy but should use staged entries. The fundamentals are strong, but the $25 billion ASR-related debt issuance increases balance-sheet sensitivity. Cash-flow growth guidance of 4%-5% is also modest compared with the strong EPS growth headline.
For conservative portfolios, the best approach is to build gradually, monitor cRPO and free cash flow, and prefer additions when the stock consolidates above the 50-day average or reclaims the 200-day average with improving guidance.
Neutral Analyst
Neutral Risk View
The neutral view supports Buy with a $250 target. Salesforce has a rare mix of double-digit revenue growth, high non-GAAP margin, substantial free cash flow, and AI growth optionality. The valuation is not demanding, and consensus targets are well above the current price.
Key monitoring points are cRPO growth, subscription and support revenue growth, Agentforce ARR, Data 360 adoption, FY2027 free cash flow growth, debt reduction after the ASR, and whether the stock can recover the 200-day average.
V. Portfolio Manager Decision
Portfolio Manager
Portfolio Manager Decision
Final Rating: Buy
Price Target: $250
Investment Snapshot
| Metric | Latest value | Why it matters |
|---|---|---|
| NYSE close (May 29, 2026) | $191.10 | Entry price for the rating and target. |
| Market capitalization | $156.51B | Salesforce remains a large-cap enterprise software platform. |
| Enterprise value | $187.22B | Debt from the accelerated share repurchase makes EV important. |
| 52-week range | $163.52-$276.80 | Shares recovered from lows but remain well below the prior high. |
| 50-day / 200-day averages | $180.81 / $221.27 | Price is above the 50-day but still below the 200-day trend. |
| Forward P/E | 12.35x | Earnings multiple is low for a profitable software platform. |
| Trailing P/E | 22.12x | Current earnings multiple is reasonable after margin expansion. |
| Price/sales | 3.65x | Sales multiple is moderate relative to large-cap software peers. |
| EV/EBITDA | 14.52x | Enterprise valuation is fair given growth and margin profile. |
| Dividend yield | 0.92% | Dividend is modest; buybacks are the larger capital return lever. |
| Analyst mean / median target | $257.03 / $250.00 | Consensus implies meaningful upside from the close. |
| Analyst high / low target | $475.00 / $160.00 | Dispersion is wide, but the base-case target is above spot. |
| Q1 FY2027 revenue | $11.1B, +13% YoY | Revenue growth accelerated with AI and platform demand. |
| Q1 cRPO | $33.6B, +14% YoY | Contracted backlog supports forward revenue visibility. |
| Q1 non-GAAP operating margin | 34.8% | Margin profile remains strong while revenue grows double digits. |
| Q1 non-GAAP diluted EPS | $3.88, +50% YoY | EPS growth is the clearest operating leverage signal. |
| Q1 free cash flow | $6.6B, +4% YoY | Cash flow remains high, though growth is muted by debt-related effects. |
| Agentforce and Data 360 ARR | Nearly $3.4B, +200%+ YoY | AI platform traction supports the growth narrative. |
| FY2027 revenue guidance | $45.9B-$46.2B, +11% YoY | Guidance supports continued double-digit growth. |
| FY2027 non-GAAP margin guide | 34.3% | Management expects high profitability to persist. |
| FY2026 revenue / FCF | $41.5B / $14.4B | Establishes the annual scale and cash generation base. |
| Total debt / cash | $42.55B / $11.84B | Balance sheet risk rose after the $25B ASR-related debt issuance. |
Salesforce should be rated Buy with a $250 target. Q1 FY2027 showed solid execution: revenue of $11.1 billion, up 13%; subscription and support revenue of $10.6 billion, up 14%; current remaining performance obligation of $33.6 billion, up 14%; non-GAAP operating margin of 34.8%; and non-GAAP diluted EPS of $3.88, up 50%.
The investment case is a combination of attractive valuation, high margins, AI product traction, and large capital return. Agentforce and Data 360 ARR was nearly $3.4 billion, up more than 200% year over year, and Salesforce is using its cash generation and buyback authorization to increase per-share value.
The main risks are higher debt after the $25 billion ASR financing, modest FY2027 free cash flow growth guidance, and the need to prove that Agentforce can become a large revenue driver rather than a narrative premium. The portfolio stance should be constructive but disciplined: buy in stages, monitor cRPO and free cash flow, and reassess if AI traction or revenue guidance weakens.